Literature DB >> 29318938

Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.

Kimberly Goodspeed1,2, Cassandra Newsom1,2, Mary Ann Morris2, Craig Powell1, Patricia Evans1,2, Sailaja Golla1,2.   

Abstract

Pitt-Hopkins syndrome (PTHS) is a rare, genetic disorder caused by a molecular variant of TCF4 which is involved in embryologic neuronal differentiation. PTHS is characterized by syndromic facies, psychomotor delay, and intellectual disability. Other associated features include early-onset myopia, seizures, constipation, and hyperventilation-apneic spells. Many also meet criteria for autism spectrum disorder. Here the authors present a series of 23 PTHS patients with molecularly confirmed TCF4 variants and describe 3 unique individuals. The first carries a small deletion but does not exhibit the typical facial features nor the typical pattern of developmental delay. The second exhibits typical facial features, but has attained more advanced motor and verbal skills than other reported cases to date. The third displays typical features of PTHS, however inherited a large chromosomal duplication involving TCF4 from his unaffected father with somatic mosaicism. To the authors' knowledge, this is the first chromosomal duplication case reported to date.

Entities:  

Keywords:  autism; behavior; developmental delay; genetics; intellectual disability; ophthalmology; pediatric; seizures

Mesh:

Substances:

Year:  2018        PMID: 29318938      PMCID: PMC5922265          DOI: 10.1177/0883073817750490

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  56 in total

Review 1.  Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  D J Michelson; M I Shevell; E H Sherr; J B Moeschler; A L Gropman; S Ashwal
Journal:  Neurology       Date:  2011-09-28       Impact factor: 9.910

2.  Deletion 18q21.2q21.32 involving TCF4 in a boy diagnosed by CGH-array.

Authors:  Joris Andrieux; Frédéric Lepretre; Jean-Marie Cuisset; Alice Goldenberg; Bruno Delobel; Sylvie Manouvrier-Hanu; Muriel Holder-Espinasse
Journal:  Eur J Med Genet       Date:  2008-01-14       Impact factor: 2.708

3.  Pitt-Hopkins syndrome: report of a case with a TCF4 gene mutation.

Authors:  Grazia Taddeucci; Alice Bonuccelli; Ilaria Mantellassi; Alessandro Orsini; Enrico Tarantino
Journal:  Ital J Pediatr       Date:  2010-02-02       Impact factor: 2.638

4.  Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction.

Authors:  Jeanne Amiel; Marlene Rio; Loic de Pontual; Richard Redon; Valerie Malan; Nathalie Boddaert; Perrine Plouin; Nigel P Carter; Stanislas Lyonnet; Arnold Munnich; Laurence Colleaux
Journal:  Am J Hum Genet       Date:  2007-03-23       Impact factor: 11.025

5.  Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function.

Authors:  Andrew J Kennedy; Elizabeth J Rahn; Brynna S Paulukaitis; Katherine E Savell; Holly B Kordasiewicz; Jing Wang; John W Lewis; Jessica Posey; Sarah K Strange; Mikael C Guzman-Karlsson; Scott E Phillips; Kyle Decker; S Timothy Motley; Eric E Swayze; David J Ecker; Todd P Michael; Jeremy J Day; J David Sweatt
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

6.  A case of Pitt-Hopkins syndrome with absence of hyperventilation.

Authors:  Adlette Inati; Hussein A Abbas; Serge Korjian; Yazan Daaboul; Mohamad Harajeily; Raya Saab
Journal:  J Child Neurol       Date:  2012-12-17       Impact factor: 1.987

Review 7.  Recognition and Management of Medical Complexity.

Authors:  Dennis Z Kuo; Amy J Houtrow
Journal:  Pediatrics       Date:  2016-12       Impact factor: 7.124

8.  Partial deletion of TCF4 in three generation family with non-syndromic intellectual disability, without features of Pitt-Hopkins syndrome.

Authors:  Mira Kharbanda; Kaja Kannike; Anne Lampe; Jonathan Berg; Tõnis Timmusk; Mari Sepp
Journal:  Eur J Med Genet       Date:  2016-04-28       Impact factor: 2.708

9.  Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome.

Authors:  Vera M Kalscheuer; Ilse Feenstra; Conny M A Van Ravenswaaij-Arts; Dominique F C M Smeets; Corinna Menzel; Reinhard Ullmann; Luciana Musante; Hans-Hilger Ropers
Journal:  Am J Med Genet A       Date:  2008-08-15       Impact factor: 2.802

10.  Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.

Authors:  Anne Gregor; Beate Albrecht; Ingrid Bader; Emilia K Bijlsma; Arif B Ekici; Hartmut Engels; Karl Hackmann; Denise Horn; Juliane Hoyer; Jakub Klapecki; Jürgen Kohlhase; Isabelle Maystadt; Sandra Nagl; Eva Prott; Sigrid Tinschert; Reinhard Ullmann; Eva Wohlleber; Geoffrey Woods; André Reis; Anita Rauch; Christiane Zweier
Journal:  BMC Med Genet       Date:  2011-08-09       Impact factor: 2.103

View more
  12 in total

1.  Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Nav1.8 Inhibitor In Vivo for Pitt Hopkins Syndrome.

Authors:  Sean Ekins; Ana C Puhl; Audrey Davidow
Journal:  Pharm Res       Date:  2020-06-11       Impact factor: 4.200

Review 2.  Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome.

Authors:  Keri Martinowich; Debamitra Das; Srinidhi Rao Sripathy; Yishan Mai; Rakaia F Kenney; Brady J Maher
Journal:  Mol Psychiatry       Date:  2022-10-12       Impact factor: 13.437

3.  A Case Report of Topiramate for Severe Breath Holding Spells in a Teenage Boy with Pitt-Hopkins Syndrome.

Authors:  Megan Bone; Kimberly Goodspeed
Journal:  Child Neurol Open       Date:  2022-04-13

Review 4.  Myelin plasticity: sculpting circuits in learning and memory.

Authors:  Wendy Xin; Jonah R Chan
Journal:  Nat Rev Neurosci       Date:  2020-10-12       Impact factor: 34.870

5.  Composite Sleep Problems Observed Across Smith-Magenis Syndrome, MBD5-Associated Neurodevelopmental Disorder, Pitt-Hopkins Syndrome, and ASD.

Authors:  Anusha Gandhi; Dihong Zhou; Joseph Alaimo; Edwin Chon; Michael D Fountain; Sarah H Elsea
Journal:  J Autism Dev Disord       Date:  2021-06

Review 6.  Transcription factor 4 and its association with psychiatric disorders.

Authors:  José R Teixeira; Ryan A Szeto; Vinicius M A Carvalho; Alysson R Muotri; Fabio Papes
Journal:  Transl Psychiatry       Date:  2021-01-05       Impact factor: 6.222

7.  Pitt-Hopkins syndrome: phenotypic and genotypic description of four unrelated patients and structural analysis of corresponding missense mutations.

Authors:  Tingting Zhao; Georgi Z Genchev; Shengnan Wu; Guangjun Yu; Hui Lu; Jincai Feng
Journal:  Neurogenetics       Date:  2021-06-14       Impact factor: 2.660

8.  Region and Cell Type Distribution of TCF4 in the Postnatal Mouse Brain.

Authors:  Hyojin Kim; Noah C Berens; Nicole E Ochandarena; Benjamin D Philpot
Journal:  Front Neuroanat       Date:  2020-07-17       Impact factor: 3.856

9.  Pitt-Hopkins Syndrome: Clinical and Molecular Findings of a 5-Year-Old Patient.

Authors:  Florin Tripon; Alina Bogliș; Cristian Micheu; Ioana Streață; Claudia Bănescu
Journal:  Genes (Basel)       Date:  2020-05-28       Impact factor: 4.096

10.  Behavioural and psychological characteristics in Pitt-Hopkins syndrome: a comparison with Angelman and Cornelia de Lange syndromes.

Authors:  Alice Watkins; Stacey Bissell; Jo Moss; Chris Oliver; Jill Clayton-Smith; Lorraine Haye; Mary Heald; Alice Welham
Journal:  J Neurodev Disord       Date:  2019-10-05       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.